Picture Berlin Partner HealthCapital Bionnale 2019 Germany May 650x80px
Organisation › Details

Polyphor Ltd. (SIX: POLN)

Polyphor is a clinical stage, Swiss biopharmaceutical company which has discovered and is developing the OMPTA (Outer Membrane Protein Targeting Antibiotics). The OMPTA are potentially the first new class of antibiotics against Gram-negative bacteria to have reached phase III stage in the last 50 years. The company's lead product, murepavadin, (POL7080) is in Phase III development against Pseudomonas aeruginosa - recognized as a critical priority 1 pathogen by WHO. Polyphor is also developing an immuno-oncology candidate, balixafortide (POL6326), which has achieved clinical proof of concept in a Phase Ib/proof of concept study in combination with eribulin in patients with advanced breast cancer, and a pipeline of further preclinical antibiotics based on its OMPTA platform. Polyphor is based in Allschwil near Basel and is listed on the Swiss Stock Exchange (SIX: POLN). *


Period Start 2011-07-27 existent
Products Industry antibiotic
  Industry 2 murepavadin (POL7080)
Persons Person Batur, Gökhan (Polyphor 202001– promoted to CEO joined 201906 as CCO before Merck (US))
  Person 2 Levett, Hernan (Polyphor 202001 CFO)
Region Region Allschwil BL
  Country Switzerland
  Street 125 Hegenheimermattweg
  City 4123 Allschwil BL
  Tel +41-61-567-1600
    Address record changed: 2018-07-24
Basic data Employees C: 51 to 100 (2013-11-04)
  Currency CHF
  Annual sales 6,545,595 (revenue, total, consolidated (2018) 2018-12-31)
  Profit -50,920,282 (2018-12-31)
  Cash 113,809,266 (2018-12-31)
    * Document for �About Section�: Polyphor Ltd.. (7/17/18). "Press Release: Polyphor Announces Listing of New Shares Related to the Convertible Loan Facility Agreement with the Wellcome Trust (Ad-hoc Announcement)".
Record changed: 2020-01-25


Picture [LSUS] – The Business Web Portal 650x65px

More documents for Polyphor Ltd. (SIX: POLN)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture Kentro Design Corporate and Web Design Berlin 650x65px

» top